why choose us

First received: April 23, 2023

Clinical Trial: PRISM Neurofeedback Training for MDD Anhedonic Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Depression

Study Type: INTERVENTIONAL


Official Title: Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes

Brief Summary: The goal of this interventional double-blind study is to demonstrate the safety and efficacy of PRISM neurofeedback training within an MDD Anhedonia sample.The goals of this study include:Demonstrating the safety and efficacy of Prism Neurofeedback training within an MDD Anhedonia sample;Identifying clinical profile/symptoms-based biomarkers (e.g., Hamilton Depression Rating Scale - HDRS-21, Dimensional Anhedonia Rating Scale - DARS, Snaith-Hamilton Pleasure Scale for Clinicians SHAPS) scores that can be used…

Read more